# Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest

> **NCT06744361** · PHASE2 · RECRUITING · sponsor: **Christian Hassager** · enrollment: 282 (estimated)

## Conditions studied

- Out-of-hospital Cardiac Arrest (OHCA)

## Interventions

- **DRUG:** esketamine hydrochloride
- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT06744361
- **Lead sponsor:** Christian Hassager
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-12
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 282 (ESTIMATED)
- **Last updated:** 2024-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06744361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06744361, "Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06744361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*